Amgen (AMGN)

R&D Expense Growth

8.67%

Quarterly · Period ending:

AMGN logo

AMGN R&D Expense Growth

Latest reported8.67%
AMGN Quarterly R&D Growth (QoQ) (0.00% → 8.67%)
High-resolution chart · PNG

AMGN r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Amgen R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
8.6678%
-20.0837%
13.2105%
8.945%
17.362%
-13.8051%
18.8966%
0.2073%
7.7439%
-12.4511%
42.1687%
-3.0548%
5.1985%
-20.0906%
19.0647%
7.026%
8.342%
-28.8576%
-5.2039%
31.4233%
11.8925%
-21.3181%
15.725%
10.166%
1.2605%
-27.439%
31.0689%
8.3333%
5.1195%
-25.6345%
27.6458%
6.5593%
14.3421%
-27.1333%
18.9282%
0.4582%
13.5241%
-28.6642%
8.8889%
10%
3.211%
-20.2196%
-2.3235%
16.0788%
7.83%
-27.5527%
21.2181%
0%
-0.8763%
-17.7742%
26.2892%
2.2751%
10.1367%
-6.3966%
6.5909%
6.5375%
12.2283%
-13.5135%
11.8265%
-7.0818%
11.2772%
-13.8173%
18.7761%
6.5185%
4.4892%
-27.4972%
37.7125%
-6.6378%
9.4787%
-20.6767%
9.465%
-9.8888%
16.5706%
-15.5718%
5.9278%
-5.0184%
-3.9953%
-19.0295%
20.5275%
10.6599%
20.3053%
-0.9077%
17.6157%
-0.8818%
8.2061%
-15.0729%
22.9084%
7.265%
6.1224%
-12.3086%
23.2598%
3.6322%
12.0695%
-4.2779%
17.4024%
33.8185%
14.8476%
-12.5537%
7.2384%
3.8793%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.